DOJ Subpoenas Expand in Child Transgender Care Probe

The Department of Justice has issued more than 20 subpoenas to doctors, clinics, and drug manufacturers involved in providing gender-affirming care to minors, investigating potential healthcare fraud, false statements, and deceptive marketing practices. This follows directives from Attorney General Pam Bondi and President Donald Trump's executive orders that ban federal support for sex change procedures in children and mandate strict enforcement of related laws. The FTC has also expressed interest in examining the transgender medicine industry under consumer protection laws. While major American medical organizations support gender-affirming care for minors, critics view the investigations as attempts to intimidate providers and restrict access, whereas supporters say they protect children. The actions come amid increasing state-level restrictions and a Supreme Court decision upholding Tennessee's ban on such treatments. The DOJ has not yet disclosed who received subpoenas or filed any charges.